Immediate Impact

5 from Science/Nature 82 standout
Sub-graph 1 of 18

Citing Papers

Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
2 intermediate papers

Works of Minden Collamore being referenced

Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer
2010

Author Peers

Author Last Decade Papers Cites
Minden Collamore 466 389 616 8 1.2k
Mark Malin 294 369 157 13 1.3k
Natalie Seach 270 284 220 19 1.3k
Russell Marians 243 563 779 16 1.5k
Françoise Wilkin 158 501 346 18 1.2k
Douglas Burtrum 438 800 293 18 1.6k
J W Voss 125 572 582 10 1.3k
Morten G. Rasch 569 551 139 16 1.5k
J. Barra 223 633 250 10 1.1k
Pieter Faber 223 1016 171 22 1.6k
Xiao Hui Liao 80 569 271 15 1.0k

All Works

Loading papers...

Rankless by CCL
2026